The progression of AMD is linked to the imbalance of primarily vascular endothelial growth factor A (VEGF A) and less frequently other growth factors and cytokines, leading to choroidal neovascularization (CNV), which breaches the subretinal pigment epithelium, causing disease progression and treatment resistance [1, 2]. Here, VEGFA is linked to choroidal neovascularization.